Department of Communication

Home » Miscellaneous » Cipla wins Global Fund ARV tender

Cipla wins Global Fund ARV tender

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 38 other followers

Follow us on Twitter


MUMBAI: Pharma company Cipla secured a tender worth $188.95 million for manufacturing anti-retroviral (ARV) drug for treating HIV/ AIDS, the company announced on Friday.The tender was awarded by Global Fund, an organisation working towards ending AIDS.

“The tender offered to us allows us to make HIV/AIDS treatment accessible to more than 140 countries through Global Fund,” Mr Subhanu Saxena, MD and CEO, Cipla Limited said in press release.

Cipla supplies subsidised drug for HIV/AIDS since 2001. It has successfully signed a Supplier Partnership Agreement as a ‘Panel Supplier’. This contract is effective from January 1 2015. The supplies will begin from quarter four of the financial year.

– Beacon Bureau


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: